Growth Metrics

Merck (MRK) Gross Margin Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -59.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -8.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 188.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -374.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 458.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 234.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -1,705.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -270.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -374.00
Dec 31, 2025 -935.00
Sep 30, 2025 218.00
Jun 30, 2025 74.00
Mar 31, 2025 42.00
Dec 31, 2024 224.00
Sep 30, 2024 222.00
Jun 30, 2024 352.00
Mar 31, 2024 466.00
Dec 31, 2023 132.00
Sep 30, 2023 -41.00
Jun 30, 2023 213.00
Mar 31, 2023 673.00
Dec 31, 2022 59.00
Sep 30, 2022 -7.00
Jun 30, 2022 -167.00
Mar 31, 2022 -373.00
Dec 31, 2021 1,728.00
Sep 30, 2021 134.00
Jun 30, 2021 215.00
Mar 31, 2021 -263.00
Dec 31, 2020 -802.00
Sep 30, 2020 462.00
Jun 30, 2020 -45.00
Mar 31, 2020 75.00
Dec 31, 2019 -801.00
Sep 30, 2019 134.00
Jun 30, 2019 373.00
Mar 31, 2019 351.00
Dec 31, 2018 307.00
Sep 30, 2018 -150.00
Jun 30, 2018 -127.00
Mar 31, 2018 60.00
Dec 31, 2017 134.00
Sep 30, 2017 33.00
Jun 30, 2017 497.00
Mar 31, 2017 604.00
Dec 31, 2016 337.00
Sep 30, 2016 498.00
Jun 30, 2016 202.00
Mar 31, 2016 -49.00
Dec 31, 2015 -192.00
Sep 30, 2015 266.00
Jun 30, 2015 639.00
Mar 31, 2015 16.00
Dec 31, 2014 493.00
Sep 30, 2014 -280.00
Jun 30, 2014 -584.00
Mar 31, 2014 -93.00
Dec 31, 2013 -525.00
Sep 30, 2013 -119.00
Jun 30, 2013 -551.00
Mar 31, 2013 -269.00
Dec 31, 2012 -148.00
Sep 30, 2012 19.00
Jun 30, 2012 186.00
Mar 31, 2012 64.00
Dec 31, 2011 274.00
Sep 30, 2011 147.00
Jun 30, 2011 484.00
Mar 31, 2011 1,061.00
Dec 31, 2010 1,185.00
Sep 30, 2010 -1,403.00
Jun 30, 2010 -1,715.00
Mar 31, 2010 -2,090.00